Physician profile
Mohammad O Daoud
NPI 1508218033
$1,139.34
in general payments reported to CMS, 2019-2025
19 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478 · 2020: $38.64 · 2021: $87.26 · 2022: $217 · 2023: $40.23 · 2024: $137 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $298 · Education: $19.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $298.45 |
| Education | $19.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $264.00 | 2021-2025 | Minimed 780g, Minimed 770g, Inpen Smart Insulin Delivery System |
| Astrazeneca Pharmaceuticals Lp | $250.14 | 2019-2022 | |
| Medtronic Minimed, INC. | $131.20 | 2019 | |
| Ascendis Pharma Endocrinology INC | $97.93 | 2025 | |
| Sanofi-Aventis U.S. LLC | $57.86 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $56.23 | 2019 | |
| Insulet Corporation | $52.53 | 2019-2021 | |
| Novo Nordisk INC | $48.20 | 2019-2025 | Wegovy |
| Shire North American Group INC | $35.64 | 2019 | |
| Pfizer INC. | $19.89 | 2024 | |
| Lilly USA, LLC | $16.79 | 2019 | |
| Abbott Laboratories | $16.50 | 2024 | Freestyle Libre 3 |
| Averitas Pharma INC. | $14.97 | 2024 | Qutenza |
| Horizon Therapeutics Plc | $14.68 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.82 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cequr Corporation | $12.46 | 2024 | Cequr Simplicity |
| Amarin Pharma, INC. | $12.33 | 2019 | |
| Xeris Pharmaceuticals, INC. | $12.33 | 2022 | |
| Radius Health, INC. | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Daoud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.